Total Valuation
Amgen has a market cap or net worth of HK$1.76T. The enterprise value is HK$240.31K.
Market CapHK$1.76T
Enterprise ValueHK$240.31K
Share Statistics
Amgen has 540,632,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding540,632,000
Owned by Insiders0.21%
Owned by Institutions18.40%
Financial Efficiency
Amgen’s return on equity (ROE) is 0.89 and return on invested capital (ROIC) is 13.16%.
Return on Equity (ROE)0.89
Return on Assets (ROA)0.09
Return on Invested Capital (ROIC)13.16%
Return on Capital Employed (ROCE)0.16
Revenue Per Employee1.17M
Profits Per Employee244.79K
Employee Count31,500
Asset Turnover0.41
Inventory Turnover1.72
Valuation Ratios
The current PE Ratio of Amgen is 25.9. Amgen’s PEG ratio is 0.26.
PE Ratio25.9
PS Ratio4.79
PB Ratio20.34
Price to Fair Value20.34
Price to FCF21.74
Price to Operating Cash Flow18.15
PEG Ratio0.26
Income Statement
In the last 12 months, Amgen had revenue of 36.74B and earned 7.71B in profits. Earnings per share was 14.33.
Revenue36.74B
Gross Profit26.01B
Operating Income10.68B
Pretax Income8.98B
Net Income7.71B
EBITDA16.90B
Earnings Per Share (EPS)14.33
Cash Flow
In the last 12 months, operating cash flow was 12.48B and capital expenditures -2.30B, giving a free cash flow of 10.18B billion.
Operating Cash Flow12.48B
Free Cash Flow10.18B
Free Cash Flow per Share18.82
Dividends & Yields
Amgen pays an annual dividend of HK$19.772, resulting in a dividend yield of 39524.74%
Dividend Per ShareHK$19.772
Dividend Yield39524.74%
Payout Ratio44.33%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.00
52-Week Price Change-99.99%
50-Day Moving Average1.76K
200-Day Moving Average1.74K
Relative Strength Index (RSI)0.01
Average Volume (3m)0.00
Important Dates
Amgen upcoming earnings date is Nov 3, 2026, After Close (Confirmed).
Last Earnings DateAug 4, 2026
Next Earnings DateNov 3, 2026
Ex-Dividend Date―
Financial Position
Amgen as a current ratio of 1.14, with Debt / Equity ratio of 490.28%
Current Ratio1.14
Quick Ratio0.90
Debt to Market Cap0.31
Net Debt to EBITDA2.69
Interest Coverage Ratio3.88
Taxes
In the past 12 months, Amgen has paid 1.26B in taxes.
Income Tax1.26B
Effective Tax Rate0.14
Enterprise Valuation
Amgen EV to EBITDA ratio is 13.11, with an EV/FCF ratio of 27.35.
EV to Sales6.03
EV to EBITDA13.11
EV to Free Cash Flow27.35
EV to Operating Cash Flow22.25
Balance Sheet
Amgen has HK$13.99B in cash and marketable securities with HK$57.30B in debt, giving a net cash position of -HK$43.31B billion.
Cash & Marketable SecuritiesHK$13.99B
Total DebtHK$57.30B
Net Cash-HK$43.31B
Net Cash Per Share-HK$80.12
Tangible Book Value Per Share-HK$60.03
Margins
Gross margin is 72.65%, with operating margin of 29.06%, and net profit margin of 20.99%.
Gross Margin72.65%
Operating Margin29.06%
Pretax Margin24.43%
Net Profit Margin20.99%
EBITDA Margin45.99%
EBIT Margin31.93%
Analyst Forecast
The average price target for Amgen is HK$3,056.54, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetHK$3,056.54
Price Target Upside1697980.43% Upside
Analyst ConsensusModerate Buy
Analyst Count22
Revenue Growth Forecast10.20%
EPS Growth Forecast32.09%